儿童系统性硬化症无皮肤硬化型:首个小样本病例系列
该研究回顾性分析单中心20年52例幼年系统性硬化症(JSSc)患者,其中5例(9.6%)为无皮肤受累的sine scleroderma型(ssJSSc),并与经典JSSc比较。ssJSSc诊断延迟更长(20.1 vs 8.3个月,P=0.017)、心脏受累率更高(85.7% vs 15.6%,P=0.001)、死亡或终末期器官衰竭率更高(42.9% vs 6.2%,P<0.001)。结论认为心脏受累是ssJSSc最重要特征,对孤立性心肌病或PAH/ILD患者需全面风湿科评估。
要点
- ssJSSc占JSSc的9.6%,诊断延迟显著长于经典JSSc。
- ssJSSc心脏受累率85.7%,显著高于经典JSSc的15.6%。
- ssJSSc死亡或终末期器官衰竭率达42.9%,预后更差。
核心结论
- 心脏受累是ssJSSc最重要特征,伴高致残率和死亡率。
- 诊断延迟更长提示对孤立性心肌病或PAH/ILD患者需全面风湿科评估。
研究设计与样本
- 单中心回顾性研究,20年间共52例JSSc患者,其中5例(9.6%)为ssJSSc。
- ssJSSc定义为无皮肤受累但具备RP、ANA阳性及肠道动力障碍和/或ILD或PAH和/或心脏或肾脏受累等硬皮病特征。
- 将ssJSSc与经典JSSc(cJSSc)比较,并纳入文献中仅有的2例ssJSSc患者数据。
主要发现
- 6例患者以心脏受累为首发表现,其中3例原发性心肌病,3例继发于PAH。
- 2例患者在短暂病程后死亡,1例迅速接受心脏移植。
- ssJSSc诊断延迟为20.1个月,显著长于cJSSc的8.3个月(P=0.017)。
- ssJSSc心脏受累率为85.7%,显著高于cJSSc的15.6%(P=0.001)。
- ssJSSc死亡或终末期器官衰竭率为42.9%,显著高于cJSSc的6.2%(P<0.001)。
关键数值与推荐
- ssJSSc定义:无皮肤受累,但具备RP、ANA阳性及肠道动力障碍和/或ILD或PAH和/或心脏或肾脏受累。
- 诊断延迟:ssJSSc 20.1个月 vs cJSSc 8.3个月,P=0.017。
- 心脏受累率:ssJSSc 85.7% vs cJSSc 15.6%,P=0.001。
- 死亡或终末期器官衰竭率:ssJSSc 42.9% vs cJSSc 6.2%,P<0.001。
临床怎么用
- 对无皮肤硬化但出现孤立性心肌病、PAH或ILD的患儿,应警惕ssJSSc并完成全面风湿科评估。
- ssJSSc患者需重点筛查和监测心脏受累,因其发生率高且预后差。
局限性
- 单中心回顾性研究,ssJSSc样本量小(5例),部分比较纳入文献病例。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Juvenile systemic sclerosis (JSSc) is a rare condition in childhood and its variety with no skin involvement, sine scleroderma (ssJSSc), is anecdotal. We report the first case series of patients with ssJSSc. METHODS: Demographic, clinical and laboratory data of patients with JSSc followed at our centre were retrospectively collected. Patients with no skin involvement but with all of the features RP, positive ANA, intestinal dysmotility and/or interstitial lung disease (ILD) or pulmonary arterial hypertension (PAH) and/or cardiac or renal involvement typical of scleroderma were defined as having ssJSSc and compared with those with classic JSSc (cJSSc). RESULTS: Among 52 JSSc patients seen in 20 years, five (9.6%) presented with ssJSSc. Their clinical features and those of the only two patients reported in the literature so far were compared with classic JSSc with available complete data. Six patients had cardiac involvement as presenting feature, three primary cardiomyopathy, three secondary to PAH. Two patients died after a brief disease course and one rapidly underwent heart transplantation. In comparison with cJSSc, ssJSSc showed a significantly longer diagnostic delay (20.1 vs 8.3 months, P = 0.017), higher frequency of cardiac involvement (85.7 vs 15.6%, P = 0.001) and worse outcome, intended as mortality or end-stage organ failure rates (42.9% vs 6.2%, P < 0.001). CONCLUSION: Cardiac involvement represents the most important characteristic of ssJSSc and carries a high morbidity and mortality rate. The longer delay in diagnosis underlines the need for a comprehensive rheumatological work-up in patients with isolated cardiomyopathy or PAH/ILD.
引用
- Zulian F, Lanzoni G, Castaldi B, et al. Systemic sclerosis sine scleroderma in children. Rheumatology (Oxford). 2022. PMID: 34605913. doi:10.1093/rheumatology/keab738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。